Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
12/03/1997 | CN1036587C Process for preparation of cephalosporin antibiotic |
12/03/1997 | CN1036569C Method of producing skin-rubbing agent for curing the dysentery and diarrhoed of domestic animals |
12/02/1997 | US5693858 Organic salts of N,N'-diacetyl cystine |
12/02/1997 | US5693857 Process and intermediate for the preparation of 2-hydroxy-3-sulfido-3-phenyl propanoic acids |
12/02/1997 | US5693850 Nutritive water soluble glycerol esters of hydroxy butyric acid |
12/02/1997 | US5693844 2-cyano-3-hydroxy-propenamides |
12/02/1997 | US5693827 Treatment of HIV infections and compounds useful therein |
12/02/1997 | US5693818 Process for preparing pure salts of pyridinylmethyl-sulfinyl-1H-benzimidazole |
12/02/1997 | US5693814 Crystals of antimicrobial compound |
12/02/1997 | US5693805 Sulfonamidation of chlorosulfonylcamphor with piperazine derivative salt, oximation, reduction, selective amidation of endo amine isomer, salt formation; tocolytic agents |
12/02/1997 | US5693804 Substituted 1-aryl-3-piperazin-1'-yl propanones |
12/02/1997 | US5693803 Epoxide intermediates formed by reacting amine nucleophile with activated glycidyl derivative |
12/02/1997 | US5693800 N-(2-amino-4,6-dichloropyrimidine-5-yl) formamide and a process for its preparation |
12/02/1997 | US5693795 Process for the manufacture of 4H-imidazo 1,5-A! 1,4!benzodiazepines |
12/02/1997 | US5693790 Crystalline form of a cephalosporin antibiotic |
12/02/1997 | US5693787 Stereospecific |
12/02/1997 | US5693775 Fibroblast growth factor homologous factor-1 (FHF-1) and methods of use |
12/02/1997 | US5693772 Desalaninebenanomicin A derivatives and processes for the preparation thereof |
12/02/1997 | US5693769 Glycosylated steroid derivatives for transport across biological membranes and process for making and using same |
12/02/1997 | US5693751 Water soluble high molecular weight polymerized drug preparation |
12/02/1997 | US5693750 Microbiocidal action against pneumocystis infections |
12/02/1997 | US5693676 Using nitroglycerin to treat anal fissures or ulcers, hemorrhoids, levator spasms |
12/02/1997 | US5693675 Alkylated amine polymers |
12/02/1997 | US5693674 Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis |
12/02/1997 | US5693673 Process of preparing 2,2'-(1-methyl-1,2-ethanediylidene)bis hydrazine caroximidamide! |
12/02/1997 | US5693672 3,4,5-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicament containing them |
12/02/1997 | US5693671 Isomer is administered orally |
12/02/1997 | US5693670 Composition containing a dihydroxyacetone precursor |
12/02/1997 | US5693669 Dissolving tilidine in mixture of isopropanol and water, mild heating and stirring while adding phosphoric acid, then cooling and crystallization yields stable tilidine dihydrogen orthophosphate |
12/02/1997 | US5693667 Fungicides for the control of take-all disease of plants |
12/02/1997 | US5693666 Used in treating mammalian tumors |
12/02/1997 | US5693665 Alkylated (hetero) cyclic compounds |
12/02/1997 | US5693664 Use of R-(+)-α-lipoic acid, R-(-)dihydrolipoic acid and metabolites in the form of the free acid or salts or esters or amides for the preparation of drugs for the treatment of diabetes mellitus as well as of its sequelae |
12/02/1997 | US5693661 Viricides against rhinoviruses, picornaviruses |
12/02/1997 | US5693657 Useful for treating hypercholesterolemia or atherosclerosis |
12/02/1997 | US5693656 Methods for inhibiting endometriosis |
12/02/1997 | US5693655 Substituted di-indolylpiperidines for treatment of nervous system disorders |
12/02/1997 | US5693654 Medicaments for treating intraocular pressure |
12/02/1997 | US5693653 Administering an antidepressants |
12/02/1997 | US5693652 Benzimidazoles for ischemic heart conditions |
12/02/1997 | US5693651 Quinoline derivatives |
12/02/1997 | US5693650 4-(Quinolin-2-yl-methoxy)-phenyl-acetic acid derivatives |
12/02/1997 | US5693649 N-substituted azaheterocyclic carboxylic acids and esters thereof |
12/02/1997 | US5693645 Use of spiperone or spiperone derivatives as immunosuppressant agents |
12/02/1997 | US5693642 Anxiolytic and hypotensive agents; antidepressants; psychological disorders; controllers of sleep/wake cycle, eating and sexual disorders |
12/02/1997 | US5693641 Enzyme inhibitor treating blood disorder |
12/02/1997 | US5693639 Therapeutic heterocyclyl amionosulfonyl phenyl compounds |
12/02/1997 | US5693638 Method of treating a migraine headache |
12/02/1997 | US5693637 Bicycle derivatives, their preparation and use |
12/02/1997 | US5693636 Bicyclic fibrinogen antagonists |
12/02/1997 | US5693634 For systemic and topical treatment of humans and animals; veterinary medicine |
12/02/1997 | US5693633 Angiotensin II antagonists |
12/02/1997 | US5693630 Phenylethyl and phenylpropylamines |
12/02/1997 | US5693628 11-benzaldoxime-estra-diene derivatives, methods for their production and pharmaceuticals containing these compounds |
12/02/1997 | US5693627 Use of phosphotyrosine phosphatase inhibitors for controlling cellular proliferation |
12/02/1997 | US5693626 Treating or preventing fungal infections by oral or parenteral administration |
12/02/1997 | US5693625 Administering dextran functionalized with carboxymethyl groups and benzylamide or benzylamide sulfonate groups to skin or cornea |
12/02/1997 | US5693623 Topical preparations for the treatment of acne and acneiform dermatitis |
12/02/1997 | US5693621 Inhibiting binding of selectin to carbohydrate ligands |
12/02/1997 | US5693619 Method of using renin inhibiting N-(2-amino-2-oxoethyl) butanediamide derivatives |
12/02/1997 | US5693617 Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein |
12/02/1997 | US5693614 Drug for the treatment of senile dementia of the ischemic and hypoglycemic types |
12/02/1997 | US5693530 Recombinant vectors; vaccines |
12/02/1997 | US5693521 Membrane-permeant second messengers |
12/02/1997 | US5693492 Purified dna molecule encoding drosophila avermectin and/or glutamate binding protein which functions as glutamate-gated anion channel |
12/02/1997 | US5693335 Using a mixture of (1) a polyhydric thioalcohol having at least one mercapto and one hydroxy group and (2) a fatty acid or ester; transdermal patches; estrogen therapy |
12/02/1997 | US5693321 Polymers containing diester units |
12/02/1997 | US5693319 Polyamines and method for preparation thereof |
12/02/1997 | US5693312 Pharmaceutical composition having analgesic activity |
12/02/1997 | US5693311 Polyiodinated compounds, process for preparing them and diagnostic compositions |
12/02/1997 | US5692302 Wound healing agent comprises pyruvic acid or salt, antioxidant, fatty acid mixture |
12/02/1997 | CA2052679C Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets |
12/02/1997 | CA2050639C Arylalkylamines, process for preparing them and pharmaceutical compositions containing them |
12/02/1997 | CA2010011C N-phenyl-n-(4-piperidinyl) amides useful as analgesics |
11/30/1997 | CA2206469A1 Preparation of substituted alkenoic acids |
11/30/1997 | CA2206466A1 Carbamoyl substituted heterocycles |
11/30/1997 | CA2205770A1 Process for producing paroxetine |
11/29/1997 | CA2206201A1 Pyrazole derivatives and their pharmaceutical use |
11/29/1997 | CA2177553A1 Thiazolidinedione derivatives or salts thereof and pharmaceutical compositions containing the same |
11/28/1997 | CA2206198A1 Bis-ortho-substituted benzoylguanidines, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them |
11/27/1997 | WO1997044474A2 Viral particles which are masked or unmasked with respect to a cell receptor |
11/27/1997 | WO1997044468A1 HUMAN INTERLEUKIN-1j AND ANTAGONISTS THEREOF |
11/27/1997 | WO1997044461A2 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
11/27/1997 | WO1997044460A1 Modulators of tissue regeneration |
11/27/1997 | WO1997044454A2 Human phospholipase inhibitor |
11/27/1997 | WO1997044453A1 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
11/27/1997 | WO1997044441A1 New antigen presenting cells, a process for preparing the same and their use as cellular vaccines |
11/27/1997 | WO1997044360A1 Novel human g-protein coupled receptor |
11/27/1997 | WO1997044359A1 Novel human g-protein coupled receptor |
11/27/1997 | WO1997044357A1 Synthetic glucagon binding proteins |
11/27/1997 | WO1997044356A2 RET LIGAND (RetL) FOR STIMULATING NEURAL AND RENAL GROWTH |
11/27/1997 | WO1997044354A2 Synthesis of soluble beta-sheet forming peptides |
11/27/1997 | WO1997044352A1 Modulating the activity of hormones or their receptors - peptides, antibodies, vaccines and uses thereof |
11/27/1997 | WO1997044350A1 Inhibitors of protein farnesyl transferase |
11/27/1997 | WO1997044349A1 BLOCKING EXPRESSION OF VIRULENCE FACTORS IN $i(S. AUREUS) |
11/27/1997 | WO1997044343A1 Phosphorus containing cythesine derivatives |
11/27/1997 | WO1997044342A1 PROCESS FOR PREPARING 1-ARYL-4-OXOPYRROLO[3,2-c]QUINOLINE DERIVATIVES |
11/27/1997 | WO1997044339A1 Antagonists of gonadotropin releasing hormone |
11/27/1997 | WO1997044337A1 Benzofuran carboxamides and their therapeutic use |
11/27/1997 | WO1997044336A1 Conjugates of cis-docosahexaenoic acid and paclitaxel |